Medications starting with
Ukraine-
The drug is prescribed for adults to treat neuropathic pain (resulting from peripheral and central nervous system damage), as adjunctive therapy for epilepsy (partial seizures), and for the treatment of generalized anxiety disorder and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 150 mg ATC code: N03AX16
Manufacturer: Farmak JSC
-
The drug is used to treat viral eye infections, specifically herpes infection.
Dosage form: drops, ophthalmic
Active substance Dosage interferon alpha 2b 1 000 000 IU ATC code: S01XA
Manufacturer: FZ "STADA" LLC
-
The drug is used to treat inflammatory eye diseases accompanied by superficial bacterial infection, as well as to relieve inflammation in the postoperative period.
Dosage form: drops, ophthalmic, suspension
Active substance Dosage ciprofloxacin 3 mg/ml dexamethasone 1 mg/ml ATC code: S01CA01
Manufacturer: Farmak JSC
-
The drug is used to treat eye infections (e.g., conjunctivitis, keratitis), eye injuries and burns, as well as to treat otitis (ear inflammation) and rhinitis (inflammation of the nasal mucosa). It is also used for the prevention of infections in newborns and before surgeries.
Dosage form: drops, ophthalmic/otic/nasal, solution
Active substance Dosage benzyldimethyl[3-(myristoylamino)propyl]ammonium chloride 0.1 mg/ml Manufacturer: JSC "Farmak" (manufacturing, packaging, quality control)
-
The drug is prescribed for adults with nervous system diseases (vascular encephalopathy, alcoholic, post-stroke, or post-traumatic encephalopathies), chronic cerebral circulatory insufficiency (with impairments in memory, attention, speech, and dizziness), senile dementias (including Alzheimer's disease), and psychoorganic syndromes.
Dosage form: capsules
Active substance Dosage piracetam 250 mg gamma-aminobutyric acid 125 mg ATC code: N06BX
Manufacturer: JSC "Olyinpharm"
-
The drug is used to treat infected wounds and burns that are slow to heal, as well as trophic ulcers. In gynecology and proctology, it is applied for bacterial vaginosis, cervical erosion, chronic proctitis, and anal fissures.
Dosage form: aerosol
Active substance Dosage sea buckthorn oil 5.40 g chloramphenicol 1.62 g benzocaine 1.62 g boric acid 0.27 g ATC code: D03AX
Manufacturer: JSC "Stoma"
-
The drug is used to treat vitamin D deficiency and conditions related to its deficiency in adults.
Dosage form: capsules, soft gelatin
Active substance Dosage cholecalciferol 0.25 mg ATC code: A11CC05
Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (manufacturing, primary and secondary packaging, batch control; batch release)
-
These medications are prescribed for the treatment of essential arterial hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC code: C09CA08
Manufacturer: Alembic Pharmaceuticals Limited
-
These medications are prescribed for the treatment of essential arterial hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC code: C09CA08
Manufacturer: Alembic Pharmaceuticals Limited
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults who do not achieve adequate control with a single component (olmesartan medoxomil) alone.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC code: C09DA08
Manufacturer: Alembic Pharmaceuticals Limited
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC code: C09DA08
Manufacturer: Alembic Pharmaceuticals Limited
-
The drug is used for the short-term local treatment of inflammation of muscles, ligaments, tendons, and joints caused by injuries (e.g., sprains, dislocations, or contusions), as well as for local forms of rheumatism.
Dosage form: plaster, medicated
Active substance Dosage diclofenac 140 mg every 12 hours per 140 cm2 ATC code: M02AA15
-
The drug is used to relieve pain and reduce inflammation in rheumatic diseases (arthritis, osteoarthritis, etc.), acute gout attacks, renal and hepatic colic, as well as for pain, swelling, and inflammation following injuries, surgeries, or during severe migraine attacks.
Dosage form: solution for injection
Active substance Dosage diclofenac 75 mg lidocaine 20 mg ATC code: M01AB55
-
The drug is used for the topical treatment of pain and inflammation of joints, muscles, ligaments, and tendons resulting from injuries or rheumatic diseases.
Dosage form: gel
Active substance Dosage diclofenac 10 mg/g ATC code: M02AA15
-
The drug is used to reduce inflammation, pain, and swelling in rheumatic diseases (e.g., arthritis, osteoarthritis), back pain, gout, as well as for injuries, post-operative pain, and gynecological pain (primary dysmenorrhea).
Dosage form: tablets, enteric-coated
Active substance Dosage diclofenac 50 mg ATC code: M01AB05
-
The drug is used to relieve pain in rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, periarthritis of the shoulder, lumbago, sciatica, and non-articular rheumatism.
Dosage form: tablets, modified release
Active substance Dosage aceclofenac 200 mg ATC code: M01AB16
Manufacturer: Korea United Pharm., Inc.
-
The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.
Dosage form: tablets, film-coated
Active substance Dosage olanzapine 5 mg ATC code: N05AH03
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.
Dosage form: tablets, film-coated
Active substance Dosage olanzapine 10 mg ATC code: N05AH03
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is used to treat vitamin D3 deficiency and conditions caused by its lack in adults. It is also used for the prevention of vitamin D deficiency in patients at high risk.
Dosage form: capsules, soft gelatin
Active substance Dosage cholecalciferol 0.5 mg ATC code: A11CC05
-
The drug is used to treat vitamin D3 deficiency and conditions caused by its lack in adults. It is also used for the prevention of vitamin D deficiency in high-risk groups.
Dosage form: capsules, soft gelatin
Active substance Dosage cholecalciferol 1.25 mg (50000 IU) ATC code: A11CC05
-
The drug is used for the prevention of vitamin D deficiency and related conditions (e.g., rickets or osteomalacia) in adults and children aged 12 years and older. It is also prescribed as an adjunct to the treatment of osteoporosis in adults.
Dosage form: capsules, soft gelatin
Active substance Dosage cholecalciferol 50 mcg ATC code: A11CC05
Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (manufacturing, primary and secondary packaging, batch control; batch release)
-
The drug is used for the prevention of vitamin D deficiency and related conditions (e.g., osteoporosis or osteomalacia) in adults with obesity.
Dosage form: capsules, soft gelatin
Active substance Dosage cholecalciferol 100 mcg ATC code: A11CC05
Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (manufacturing, primary and secondary packaging, batch control; batch release)
-
The drug is used for parenteral (intravenous) nutrition of adults and children aged 2 years and older in cases where normal nutrition via the mouth or intestine is impossible, insufficient, or contraindicated.
Dosage form: emulsion, for infusion
Active substance Dosage mixture of amino acids glucose electrolytes and lipid emulsion olive oil and soybean oil 18.75% glucose solution with calcium 6.3% amino acid solution with electrolytes 15% lipid emulsion in the ratio 400 ml:400 ml:200 ml or 600 ml:600 ml:300 ml or 800 ml:800 ml:400 ml ATC code: B05BA10
Manufacturer: Baxter S.A. (incoming control, intermediate product control, manufacturing, packaging, quality control and batch release)
-
The drug is used for parenteral (intravenous) nutrition of adults and children aged 2 years and older in cases where normal nutrition via the mouth or intestines is impossible, insufficient, or contraindicated.
Dosage form: emulsion, for infusion
Active substance Dosage mixture of amino acids glucose electrolytes and lipid emulsion olive oil and soybean oil 0 ATC code: B05BA10
Manufacturer: Baxter S.A. (Incoming control, intermediate product control, manufacturing, packaging, quality control and batch release)
-
The drug is used for parenteral (intravenous) nutrition of adults and children aged 2 years and older in cases where normal nutrition via the mouth or intestine is impossible, insufficient, or contraindicated.
Dosage form: emulsion, for infusion
Active substance Dosage mixture of amino acids glucose electrolytes and lipid emulsion olive oil and soybean oil 0 ATC code: B05BA10
Manufacturer: Baxter S.A. (incoming control, intermediate product control, manufacturing, packaging, quality control and batch release)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC code: C09CA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is used to treat arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC code: C09CA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC code: C09CA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where taking a single component (olmesartan or amlodipine) does not allow for achieving the necessary blood pressure control.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg ATC code: C09DB02
Manufacturer: Hemofarm AD (manufacturing of unpackaged product, primary and secondary packaging, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure), especially in cases where the use of a single component does not provide the desired result.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg ATC code: C09DB02
Manufacturer: Hemofarm AD (manufacturing of unpackaged product, primary and secondary packaging, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults who do not achieve sufficient control with olmesartan medoxomil alone.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC code: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom treatment with a single component (olmesartan medoxomil) alone is insufficient.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC code: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom taking a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC code: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom treatment with a single component (olmesartan medoxomil) alone is insufficient.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 25 mg ATC code: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other drug combinations do not provide adequate blood pressure control, or as a replacement for other agents.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC code: C09DX03
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other combination agents do not provide adequate blood pressure control, or as a replacement for other medications.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC code: C09DX03
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is used to treat essential hypertension (high blood pressure) in adults, as well as hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC code: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults, as well as hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC code: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults, as well as hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC code: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where taking a single component (olmesartan or amlodipine) does not allow for achieving the necessary blood pressure control.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg ATC code: C09DB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where the administration of individual components (olmesartan or amlodipine) does not allow for achieving the necessary blood pressure control.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg ATC code: C09DB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where treatment with individual active substances does not provide adequate blood pressure control.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg ATC code: C09DB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC code: C09DX03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC code: C09DX03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is prescribed for the treatment of essential hypertension (high blood pressure) in adults, as well as for the treatment of hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC code: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of high blood pressure (essential hypertension) in adults, as well as for the treatment of hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC code: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used to treat essential hypertension (high blood pressure) in adults, as well as to treat hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC code: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the desired blood pressure level.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC code: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC code: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) for whom the use of a single component (olmesartan) alone does not achieve the required blood pressure level.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC code: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH